生殖系癌症易感变异与儿童胶质瘤:加利福尼亚州一项基于人群的研究
该研究从加利福尼亚州出生并诊断的280例儿童星形细胞瘤患者(以高级别为主)的新生儿干血斑提取DNA行全外显子测序,在175个候选癌症易感基因中分析。31例(11.1%)检出33个推定致病性生殖系变异,胶质母细胞瘤患者携带率最高(14.3%,N=9/63);TP53变异在全外显子组水平与儿童胶质母细胞瘤显著相关(OR=32.8,P=8.04×10⁻⁷)。作者认为相当比例儿童胶质瘤患者携带癌症易感基因的推定致病性变异。
要点
- 280例儿童星形细胞瘤患者中31例(11.1%)检出推定致病性生殖系变异。
- 儿童胶质母细胞瘤患者携带推定致病性生殖系变异比例最高(14.3%,N=9/63)。
- TP53推定致病性变异与儿童胶质母细胞瘤在全外显子组水平显著相关(OR=32.8,P=8.04×10⁻⁷)。
核心结论
- 相当比例的儿童胶质瘤患者,尤其是高级别者,携带癌症易感基因的推定致病性变异。
- 其中一些变异可能具有临床可操作性,或可能需要遗传咨询。
研究设计与样本
- 基于加利福尼亚州人群的研究,纳入280例在该州出生并诊断的儿童星形细胞瘤患者(以高级别为主)。
- 从新生儿干血斑提取DNA行全外显子测序,采用全外显子组基因负荷检验及175个预设候选癌症易感基因的变异鉴定。
主要发现
- 31例患者(11.1%)检出33个推定致病性生殖系变异,分布于24个基因,主要涉及DNA修复和细胞周期调控。
- 儿童胶质母细胞瘤患者最可能携带推定致病性生殖系变异(14.3%,N=9/63)。
- 5个变异位于TP53,其中4个见于胶质母细胞瘤患者(6.3%,N=4/63)。
- NF1为第二常见突变基因,4例星形细胞瘤非特指型患者检出推定致病性变异。
- 全外显子组基因负荷检验显示TP53推定致病性变异与儿童胶质母细胞瘤显著相关(OR=32.8,P=8.04×10⁻⁷)。
关键数值与推荐
- 175个预设候选癌症易感基因中检出33个推定致病性生殖系变异(31/280例,11.1%)。
- 儿童胶质母细胞瘤患者推定致病性生殖系变异携带率为14.3%(N=9/63)。
- TP53推定致病性变异在胶质母细胞瘤患者中为6.3%(N=4/63)。
- TP53推定致病性变异与儿童胶质母细胞瘤关联的OR=32.8,P=8.04×10⁻⁷。
临床怎么用
- 作者认为,部分检出的变异可能具有临床可操作性,或可能需要遗传咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pediatric astrocytoma constitutes a majority of malignant pediatric brain tumors. Previous studies that investigated pediatric cancer predisposition have primarily been conducted in tertiary referral centers and focused on cancer predisposition genes. In this study, we investigated the contribution of rare germline variants to risk of malignant pediatric astrocytoma on a population level. METHODS: DNA samples were extracted from neonatal dried bloodspots from 280 pediatric astrocytoma patients (predominantly high grade) born and diagnosed in California and were subjected to whole-exome sequencing. Sequencing data were analyzed using agnostic exome-wide gene-burden testing and variant identification for putatively pathogenic variants in 175 a priori candidate cancer-predisposition genes. RESULTS: We identified 33 putatively pathogenic germline variants among 31 patients (11.1%) which were located in 24 genes largely involved in DNA repair and cell cycle control. Patients with pediatric glioblastoma were most likely to harbor putatively pathogenic germline variants (14.3%, N = 9/63). Five variants were located in tumor protein 53 (TP53), of which 4 were identified among patients with glioblastoma (6.3%, N = 4/63). The next most frequently mutated gene was neurofibromatosis 1 (NF1), in which putatively pathogenic variants were identified in 4 patients with astrocytoma not otherwise specified. Gene-burden testing also revealed that putatively pathogenic variants in TP53 were significantly associated with pediatric glioblastoma on an exome-wide level (odds ratio, 32.8, P = 8.04 × 10-7). CONCLUSION: A considerable fraction of pediatric glioma patients, especially those of higher grade, harbor a putatively pathogenic variant in a cancer predisposition gene. Some of these variants may be clinically actionable or may warrant genetic counseling.
引用
- Muskens IS, de Smith AJ, Zhang C, et al. Germline cancer predisposition variants and pediatric glioma: a population-based study in California. Neuro Oncol. 2020. PMID: 31970404. doi:10.1093/neuonc/noaa014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。